Medicine Research news
Air pollution has already been linked to a range of health problems. Now, a ground-breaking new study suggests pollution from traffic may put women at risk for another deadly disease.
As part of McGill's "RaDiCAL" project (Rare Disease Consortium for Autosomal Loci), collaborators in Qatar conducted field research with three patients from biologically interrelated Bedouin families, and sent samples to Canada for analysis by GA JOE – a high-tech genome analyzing machine.
The Outaouais Health Campus, McGill University and their partners are happy to announce the inauguration of a new decentralized predoctoral medical education program: integrated externship. The first cohort, composed of nine students, arrived this August to pursue their medical education. The program combines clinical exposure, teaching and learning by clinical reasoning.
Proteins are made up of a chain of amino acids, and scientists have known since the 1980s that first one in the chain determines the lifetime of a protein. McGill researchers have finally discovered how the cell identifies this first amino acid – and caught it on camera.
Videoconferences may be known for putting people to sleep, but never like this. Dr. Thomas Hemmerling and his team of McGill’s Department of Anesthesia achieved a world first on August 30, 2010, when they treated patients undergoing thyroid gland surgery in Italy remotely from Montreal.
A breakthrough study focusing on the benefits of soy in the prevention of chronic pain after breast cancer surgery has been launched by researchers at the Alan Edwards Pain Management Unit of the McGill University Health Centre (MUHC) and McGill University.
“It’s a global health disaster waiting to happen, even here in Canada, but this new paradigm in TB research may offer an immediate opportunity to improve vaccination and treatment initiatives,” explains Dr. Maziar Divangahi
The Canadian Institutes of Health Research have awarded a $300,000 grant for research focusing on the nature of the immune response induced by the action mechanisms of plant-made Virus-Like Particles to Dr. Louis Vezina, Chief Scientific Officer of Medicago and to Dr. Brian Ward and Dr. Ciriaco Piccirillo of the Research Institute of the McGill University Health Centre and McGill University.
Another step on the road to a cure for diabetes may give hope to the world’s 171 million diabetes sufferers, thanks to collaboration between teams from McGill University and the University of California at San Francisco (UCSF).
People with Parkinson’s disease suffer social difficulties simply because of the way they talk, a McGill University researcher has discovered. Marc Pell, at McGill’s School of Communication Sciences and Disorders, has learned that many people develop negative impressions about individuals with Parkinson’s disease, based solely on how they communicate.
Dr. Phil Gold made Canadian medical history in 1965—and now it’s official. Forty-five years after he and his colleague Dr. Samuel Freedman discovered the carcinoembryonic antigen (CEA)—which, as the first clinically useful human tumour marker, revolutionized the diagnosis and management of cancer—Gold is being inducted into the Canadian Medical Hall of Fame.
Scientists have identified a double agent in the eye that, once triggered, can morph from neuron protector to neuron killer. The discovery has significant health implications since the neurons killed through this process results in vision loss and blindness.
Malaria causes more than two million deaths each year, but an expert multinational team battling the global spread of drug-resistant parasites has made a breakthrough in the search for better treatment.
A new study has found that Vitamin D, readily available in supplements or cod liver oil, can counter the effects of Crohn’s disease. John White, an endocrinologist at the Research Institute of the McGill University Health Centre, led a team of scientists who present their findings about the inflammatory bowel disease in the latest Journal of Biological Chemistry.
Studies of the victims of the Walkerton, Ont. tainted drinking water tragedy have led researchers to discover DNA variations in genes that increase the risk of developing post-infectious irritable bowel syndrome (PI-IBS). The sheer scale of infection and the recording of the health of Walkerton’s citizens gave a team of researchers a unique opportunity to study the origin of this disorder.